NEWS & EVENTS
Recently approved drugs,
- Exparel (Bupivacaine) Injectable Suspension (for Pain);
- Onfi (Clobazam) Tablets (for Lennox-Gastaut Syndrome);
- Ferriprox (Deferiprone) (for Hemosiderosis);
- Juvisync (Simvastatin and Sitagliptin) (for Diabetes Mellitus Type II, Homozygous Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia, Hypertriglyceridemia);
- Xalkori (Crizotinib) Capsules (for Non-Small Cell Lung Cancer);
- Firazyr (Icatibant) Injection (for Angioedema);
- Adcetris (Brentuximab vedotin) Injection (for Lymphoma, Hodgkin's Disease);
- Zelboraf (Vemurafenib) Tablets (for Melanoma – Metastatic);
- Propel (Mometasone furoate) Implant (for Sinusitis);
- Complera (Emtricitabine, Rilpivirine and Tenofovir disoproxil fumarate) Tablets (for HIV Infection)
Approximately one-third of the top-selling drugs in the world are Natural Products (NPs) or their derivatives. Moreover, NPs are widely recognized in the pharmaceutical industry for their broad structural diversity as well as their wide range of pharmacological activities. In light of these facts, why do NP drug discovery programs receive so little respect nowadays?
(for further details visit)
(for further details visit)
Admissions open for B.Pharm degree course
Admissions open for